Proficio Capital Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Proficio Capital Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-76	Closed	-$3K	–	1374
2017 Q4	$3K	Buy	76 +9	+13%	+$449	﹤0.01%	1093
2017 Q3	$3K	Hold	67	–	–	﹤0.01%	1066
2017 Q2	$2K	Hold	67	–	–	﹤0.01%	1128
2017 Q1	$2K	Buy	+67	New	+$1.44K	﹤0.01%	1172
2016 Q2	–	Sell	-10	Closed	–	–	1233
2016 Q1	$0	Buy	+10	New	+$348	﹤0.01%	1209

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Proficio Capital Partners's JUNO Position: Q1 2018 in Review

Proficio Capital Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 76 shares — an estimated $3K sold.

Proficio Capital Partners first reported a position in JUNO in Q1 2016 and held it in 5 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Proficio Capital Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Proficio Capital Partners sold 76 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3K.
Proficio Capital Partners first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 5 quarters.
Proficio Capital Partners's Juno Therapeutics, Inc. position peaked at $3K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Proficio Capital Partners's 13F filing for Q1 2018, filed 14 May 2018.